Ester Carballo‐Jane

Statistics

Publications

Citations

1.6K

H-Index

Active since

2004

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Arena Pharmaceuticals (United States)

United States Military Academy

Institut Clinique de la Souris

Ester Carballo‐Jane is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, molecular pharmacology, and medicinal chemistry.

Publications per year

2004–2022

Publications

Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia

Yin Wu, Ester Carballo‐Jane, David G. McLaren et al. · Journal of Lipid Research · 2011 · 217 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

3-(1<i>H</i>-Tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): A Partial Agonist of the Nicotinic Acid Receptor, G-Protein Coupled Receptor 109a, with Antilipolytic but No Vasodilatory Activity in Mice

Graeme Semple, Philip J. Skinner, Tawfik Gharbaoui et al. · Journal of Medicinal Chemistry · 2008 · 96 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Engineering Glucose Responsiveness Into Insulin

Niels C. Kaarsholm, Songnian Lin, Lin Yan et al. · Diabetes · 2017 · 95 citations

Medicine, Endocrinology, Pharmacology +17

In Situ Forming Injectable Thermoresponsive Hydrogels for Controlled Delivery of Biomacromolecules

Kingshuk Dutta, Ritam Das, Jing Ling et al. · ACS Omega · 2020 · 90 citations · Full text

Pharmacy, Biomedical Engineering, Pharmaceutics +17

Chemical Genetics Define the Roles of p38α and p38β in Acute and Chronic Inflammation

Stephen J. O’Keefe, John S. Mudgett, Susan Cupo et al. · Journal of Biological Chemistry · 2007 · 80 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

1–5 of 37